Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acutus Medical Inc AFIB

Healthcare Medical Devices
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or... see more

Recent & Breaking News (OTCPK:AFIB)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB

ACCESSWIRE IA April 2, 2021

Acutus Medical to Present at the 20?? Annual Needham Virtual Healthcare Conference

GlobeNewswire March 30, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB

PR Newswire March 30, 2021

Acutus Medical Board Appoints John Sheridan as a New Director

GlobeNewswire March 18, 2021

Acutus Medical Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 18, 2021

Acutus Medical Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur at 8 a.m. (Eastern Time)

GlobeNewswire March 17, 2021

Acutus Medical to Announce Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 4, 2021

Acutus Medical Receives Vizient Innovative Technology Contract

GlobeNewswire March 2, 2021

Acutus Medical Appoints Duane Wilder as Chief Commercial Officer

GlobeNewswire March 2, 2021

Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member

GlobeNewswire February 9, 2021

Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

GlobeNewswire February 4, 2021

Acutus Medical Suite of EP Products To Be Featured During Recorded Cases at AF Symposium 2021

GlobeNewswire January 28, 2021

Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results

GlobeNewswire January 13, 2021

Acutus Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference

GlobeNewswire December 28, 2020

Acutus Medical Announces CE Mark and European Launch of AcQCross(TM) Transseptal System, a Fully Integrated Family of Transseptal Crossing Products

GlobeNewswire December 10, 2020

Acutus Medical Launches AcQBlate® Force Sensing Ablation System in Europe

GlobeNewswire December 7, 2020

Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational Science Officer

GlobeNewswire November 12, 2020

Acutus Medical Reports Third Quarter 2020 Results

GlobeNewswire November 12, 2020

Acutus Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

GlobeNewswire November 5, 2020

Acutus Medical to Announce Third Quarter 2020 Financial Results

GlobeNewswire October 29, 2020